M
Mohd Wahid
Researcher at Jazan University
Publications - 80
Citations - 732
Mohd Wahid is an academic researcher from Jazan University. The author has contributed to research in topics: Genetic model & Population. The author has an hindex of 11, co-authored 69 publications receiving 455 citations. Previous affiliations of Mohd Wahid include Jamia Millia Islamia.
Papers
More filters
Journal ArticleDOI
Developments in strategies for Quorum Sensing virulence factor inhibition to combat bacterial drug resistance.
Shafiul Haque,Faraz Ahmad,Sajad Ahmad Dar,Arshad Jawed,Raju K. Mandal,Mohd Wahid,Mohtashim Lohani,Saif Khan,Vineeta Singh,Naseem Akhter +9 more
TL;DR: The present review explores the major types of multitudinous QS systems known in Gram-positive and Gram-negative bacteria and their roles in bacterial pathogenesis and drug resistance and highlights the recent advancements in discovery of promising new QS modulators and their efficiency in controlling infections caused by multidrug-resistant bacterial pathogens.
Journal ArticleDOI
A Meta-analysis of MBL2 Polymorphisms and Tuberculosis Risk
Mohammed Y. Areeshi,Raju K. Mandal,Naseem Akhter,Sajad Ahmad Dar,Sajad Ahmad Dar,Arshad Jawed,Mohd Wahid,Harishankar Mahto,Aditya K. Panda,Mohtashim Lohani,Mohtashim Lohani,Shafiul Haque,Shafiul Haque +12 more
TL;DR: MBL2 rs1800450 and rs1800451 polymorphisms play a protective role in TB infection and reinforce their critical significance as a potential genetic marker for TB resistance.
Journal ArticleDOI
Vismodegib, itraconazole and sonidegib as hedgehog pathway inhibitors and their relative competencies in the treatment of basal cell carcinomas
Mohd Wahid,Arshad Jawed,Raju K. Mandal,Sajad Ahmad Dar,Saif Khan,Naseem Akhter,Shafiul Haque,Shafiul Haque +7 more
TL;DR: The mechanism of actions of these Hh pathway inhibitors is described and the rationale for their effectiveness/non-effectiveness for the treatment of metastatic or locally advanced BCC is provided.
Journal ArticleDOI
Recent developments and obstacles in the treatment of melanoma with BRAF and MEK inhibitors.
Mohd Wahid,Arshad Jawed,Raju K. Mandal,Sajad Ahmad Dar,Naseem Akhter,Pallavi Somvanshi,Farah Khan,Mohtashim Lohani,Mohammed Y. Areeshi,Shafiul Haque +9 more
TL;DR: The current review suggests the use of BRAF and MEK inhibitors as intermittent therapy along with heat shock protein 90 (HSP90) molecules.
Journal ArticleDOI
Quorum sensing pathways in Gram-positive and -negative bacteria: potential of their interruption in abating drug resistance.
Shafiul Haque,Dinesh K. Yadav,Shekhar Chandra Bisht,Neelam Yadav,Vineeta Singh,Kashyap Kumar Dubey,Arshad Jawed,Mohd Wahid,Sajad Ahmad Dar +8 more
TL;DR: This review gives an insight into the multitudinous QS systems in Gram-positive and Gram-negative bacteria to explore their role in microbial physiology and pathogenesis and highlights the advancements in discovery of promising new targets for development of next generation antimicrobials to control infections caused by multidrug resistant bacterial pathogens.